(2E)-1-(3-bromophenyl)-3-(3-methylphenyl)prop-2-en-1-one, 95.0%, 2g

6,8-difluoro-2-methyl-1,4-dihydroquinolin-4-one, 95%, 1g

p-Tolylacetic Acid>98.0%(GC)(T)25g

2-(5-Bromo-2-methyl-2H-indazol-3-yl)propan-2-ol, 98%, 1g

4-bromo-6-methoxy-1,3-benzothiazol-2-amine, 95+%, 2.5g

4-Amino-n,2-dimethylbenzene-1-sulfonamide, 95%, 250mg

6-(Methylthio)pyrimido[5,4-d]pyrimidin-4(1H)-one, 95.0%, 250mg

Microliter syringe for HPLC, 100 µl, 1 piece

5-Fluoro-7-methyl-1H-indazole-3-carbaldehyde, 95.0%, 250mg

2-Acetoxy-2',5'-methoxybenzophenone, 90.0%, 1g

methyl 2-cyclopropyl-6-(3,5-dimethyl-1,2-oxazol-4-yl)-1H-1,3-benzodiazole-4-carboxylate, 95%, 100mg

2-(1-PHENYL-ETHYL)-2,3-DIHYDRO-ISOTHIAZOLE 1,1-DIOXIDE, 95.0%, 250mg

3-Aminodihydrothiophen-2(3H)-one hydrochloride, 95.0%, 25g